by Daniel Smoot
2020 is almost here.
And it's lineup of IPOs could make it the biggest year yet for initial public offerings.
In fact, there are at least 10 firms poised to go public in 2020.
And almost all of them have valuations over $1 billion in industries ranging from financial services, mattresses, and even travel and lodging.
It is now normal for investors to waste money on IPOs whenever they get a little extra cash.
But this creates a chance for pre-IPO investors to break from the pack.
Dovish federal and global patterns may continue to fuel bad IPOs.
But there's a solution hidden in this vicious cycle.
Investors looking to build sustainable, long-term wealth by circumventing the IPO entirely...
by Daniel Smoot
With a valuation of $2.4 billion, Postmates is another startup unicorn anticipated to go public.
But is Postmates stock a buy at its IPO? Find out, here, with our experts at Money Morning.
by Daniel Smoot
With a valuation of $7.6 billion, Robinhood has completely disrupted the e-trading market.
But is Robinhood stock a buy at its IPO? Find out, here, with our experts at Money Morning.
by Daniel Smoot
Casper Sleep has become one of the biggest mattress firms in the world with a valuation of $1.1 billion.
Here's whether you should buy Casper Sleep stock at the IPO...
The mainstream financial media is having a bearish moment when it comes to initial public offerings. In story after feature story, you're bombarded with the idea that anyone who's excited about a big-name IPO is just setting themselves up for disappointment.
On paper, that narrative makes sense. WeWork's attempt at a $47 billion debut was farcical; its valuation plummeted to $14 billion before the offering was abandoned… and the CEO fell on his sword.
Then there's Peloton. Shares dropped 11.2% in its first day of trading on Sept. 26 – a decline that, according to The Wall Street Journal, directly influenced the decision of Endeavor Group talent firm to put off its own IPO. Insiders were obviously terrified of "poor market conditions."
But these were simply two bad IPOs, two expensive failures that had Wall Street wringing its hands.
The truth is tech and life sciences firms are still IPO leaders; that segment of the market is actually doing much better than stocks overall.
And if you snatch up the shares I'm about to recommend, you'll be ahead, too...
The Dow Jones today will gain nearly 300 points on news that the U.S. and China will meet in October to discuss a resolution to the trade war.
In Brexit news, Parliament derailed Prime Minister Boris Johnson's plan for a Brexit on October 31.
Read on for more global economic developments affecting the Dow...
by
Investing in the best stocks is a proven way to build generational wealth. And there is no better time to start than when stocks are down. Of course, taking that first step can be extremely daunting, especially today. There are a lot of unknowns with this COVID-19 crisis. How long will it last? How can […]
by Daniel Smoot
Beyond Meat is the most successful IPO of 2019.
But with that success comes competition, and other food companies want a piece of the pie.
And yet another Beyond Meat rival has entered the fray.
Here’s why they’re both great buys...
2019 is a crazy hot year for big IPOs.
And while some have rocketed into the stratosphere, others have completely plummeted.
That’s why we’ve uncovered the best play on the 2019 IPO market without you having to worry about the risks of investing in IPOs.
